Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6051
CALL
Brunswick
BC
$4.97B
| $493K | ﹤0.01% |
10,100
-81,600
| -89% | -$3.9M |
|
6052
First Trust Managed Municipal ETF
FMB
$2.04B
| $493K | ﹤0.01% |
9,111
-36,446
| -80% | -$1.97M |
|
6053
CALL
ICU Medical
ICUI
$4.38B
| $493K | ﹤0.01% |
3,900
-1,400
| -26% | -$169K |
|
6054
CALL
Insteel Industries
IIIN
$590M
| $493K | ﹤0.01% |
13,600
+5,400
| +66% | +$182K |
|
6055
PUT
LiveRamp
RAMP
$2.29B
| $493K | ﹤0.01% |
18,500
+8,600
| +87% | +$213K |
|
|
AGGE
6056
DELISTED
IQ Enhanced Core Bond U.S. ETF
AGGE
| $493K | ﹤0.01% |
+24,292
| New | +$493K |
|
6057
PUT
Hexcel
HXL
$7.17B
| $492K | ﹤0.01% |
11,100
-4,400
| -28% | -$193K |
|
6058
CALL
Iridium Communications
IRDM
$4.94B
| $492K | ﹤0.01% |
60,700
+11,700
| +24% | +$98.1K |
|
6059
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.01B
| $492K | ﹤0.01% |
+27,453
| New | +$483K |
|
|
MWW
6060
CALL
DELISTED
Monster Worldwide Inc
MWW
| $492K | ﹤0.01% |
136,400
+120,200
| +742% | +$383K |
|
6061
PUT
EnerSys
ENS
$6.69B
| $491K | ﹤0.01% |
7,100
+3,400
| +92% | +$227K |
|
6062
PUT
Rayonier Advanced Materials
RYAM
$582M
| $491K | ﹤0.01% |
36,700
+6,300
| +21% | +$81.4K |
|
6063
Waste Management
WM
$87.8B
| $491K | ﹤0.01% |
7,700
-72,518
| -90% | -$4.74M |
|
|
KDNY
6064
PUT
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $491K | ﹤0.01% |
7,900
+1,960
| +33% | +$139K |
|
|
FNGN
6065
CALL
DELISTED
Financial Engines, Inc.
FNGN
| $490K | ﹤0.01% |
16,500
+7,800
| +90% | +$227K |
|
|
CLNY
6066
DELISTED
Colony Capital, Inc.
CLNY
| $490K | ﹤0.01% |
26,889
-181,662
| -87% | -$3.22M |
|
|
BWV
6067
DELISTED
iPath ETN linked to CBOE S&P 500 Buy Write Index
BWV
| $490K | ﹤0.01% |
7,266
-12,581
| -63% | -$844K |
|
6068
PUT
ArcBest
ARCB
$3.05B
| $489K | ﹤0.01% |
25,700
-4,900
| -16% | -$88.7K |
|
6069
WisdomTree International High Dividend Fund
DTH
$662M
| $489K | ﹤0.01% |
12,796
-18,659
| -59% | -$703K |
|
6070
iShares MSCI Emerging Markets Asia ETF
EEMA
$876M
| $489K | ﹤0.01% |
8,517
-16,926
| -67% | -$939K |
|
6071
Elbit Systems
ESLT
$33.2B
| $489K | ﹤0.01% |
5,100
-1,500
| -23% | -$146K |
|
6072
The GEO Group
GEO
$4.25B
| $489K | ﹤0.01% |
30,818
-180,582
| -85% | -$3.41M |
|
6073
PUT
ProShares UltraShort Real Estate
SRS
$14.2M
| $489K | ﹤0.01% |
1,788
-7,162
| -80% | -$1.91M |
|
6074
CALL
Ternium
TX
$10.8B
| $489K | ﹤0.01% |
24,900
+14,600
| +142% | +$303K |
|
6075
Universal Insurance Holdings
UVE
$1.21B
| $489K | ﹤0.01% |
19,400
+1,916
| +11% | +$43K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.